Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis

Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis

Heart failure (HF) is a serious and advanced stage of various cardiac diseases with high mortality and rehospitalization rates. Phosphoglycerate mutase 2 (PGAM2) overexpression was identified in the serum of patients with HF.

Bibliographic Details
Main Authors: Li Min, Gao Xiaoyuan, Wang Huiyun, Zhang Mingli, Li Xiaoying, Wang Shuya, Wang Shaoqin, Cao Chongfeng, Li Ying, Su Guohai
Format: Article
Language:English
Published: De Gruyter 2021-08-01
Series:Open Medicine
Subjects:
hf
biomarker
pgam2
nyha
cardiac function grading
Online Access:https://doi.org/10.1515/med-2021-0324

Internet

https://doi.org/10.1515/med-2021-0324

Similar Items